In vivo CRISPR screen identifies gene edits that strengthen CAR-T therapy against solid tumors

Дата публикации: 12-08-2026 22:40:03

For patients with blood cancers like leukemia and lymphoma, the immunotherapy known as CAR-T cell therapy can be lifesaving. Doctors remove a patient's immune cells, called T cells, engineer them in the lab to better recognize and attack cancer, and infuse them back into the bloodstream. But for solid tumors—which include lung, pancreatic, ovarian, colon, breast and other cancer types—these engineered immune cells still face too much resistance to effectively treat the disease.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Inherited gene variants may shape CAR-T therapy benefits and toxic side effects	0	8.44	24-07-2026
2	New personalised therapy targets chronic blood cancer	0	7.58	02-07-2026
3	Выявлен механизм, защищающий твердые опухоли от CAR-T иммунотерапии	0	0	15-04-2025
4	CRISPR makes prostate cancer vulnerable to immunotherapy	0	7.67	26-07-2026
5	A More Precise CAR T-Cell Approach for DIPG and DMG	0	12.46	22-01-2026
6	Ученые создали оружие против неизлечимого рака	7	8	15-07-2026
7	USC scientists just unlocked an endless supply of cancer-fighting immune cells	0	13.57	29-06-2026
8	Creatine doesn't just build muscle. It may also help fight cancer	0	9.22	08-07-2026
9	Finding a tumor's soft spot to power-up immunotherapy	0	5.45	12-08-2026
10	New, improved method to find and isolate the strongest cancer-fighting immune cells	7	8	08-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.11. Источник: medicalxpress.com.